Reproductive Endocrinology Associates of Charlotte, 1524 E Morehead St., Charlotte, 28207 NC, USA Department of Biosciences, University of Kent, Canterbury CT2 7NJ, UK
Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Jones Institute for Reproductive Medicine, 601 Colley Avenue #316, Norfolk, 23507 VA, USA.
Hum Reprod Update. 2014 Jul-Aug;20(4):571-81. doi: 10.1093/humupd/dmu016. Epub 2014 Mar 25.
Chromosomal mosaicism, the presence of two or more distinct cell lines, is prevalent throughout human pre- and post-implantation development and can lead to genetic abnormalities, miscarriages, stillbirths or live births. Due to the prevalence and significance of mosaicism in the human species, it is important to understand the origins, mechanisms and incidence of mosaicism throughout development.
Literature searches were conducted utilizing Pubmed, with emphasis on human pre- and post-implantation mosaicism.
Mosaicism persists in two separate forms: general and confined. General mosaicism is routine during human embryonic growth as detected by preimplantation genetic screening at either the cleavage or blastocyst stage, leading to mosaicism within both the placenta and fetus proper. Confined mosaicism has been reported in the brain, gonads and placenta, amongst other places. Mosaicism is derived from a variety of mechanisms including chromosome non-disjunction, anaphase lagging or endoreplication. Anaphase lagging has been implicated as the main process by which mosaicism arises in the preimplantation embryo. Furthermore, mosaicism can be caused by any one of numerous factors from paternal, maternal or exogenous factors such as culture media or possibly controlled ovarian hyperstimulation during in vitro fertilization (IVF). Mosaicism has been reported in as high as 70 and 90% of cleavage- and blastocyst-stage embryos derived from IVF, respectively.
The clinical consequences of mosaicism depend on which chromosome is involved, and when and where an error occurs. Mitotic rescue of a meiotic error or a very early mitotic error will typically lead to general mosaicism while a mitotic error at a specific cell lineage point typically leads to confined mosaicism. The clinical consequences of mosaicism are dependent on numerous aspects, with the consequences being unique for each event.
染色体嵌合体,即两种或多种不同细胞系的存在,在人类植入前和植入后发育过程中普遍存在,并可导致遗传异常、流产、死产或活产。由于嵌合体在人类中的普遍性和重要性,了解整个发育过程中嵌合体的起源、机制和发生率非常重要。
利用 Pubmed 进行文献检索,重点关注人类植入前和植入后的嵌合体。
嵌合体以两种不同的形式持续存在:普遍和局限。普遍嵌合体是人类胚胎生长过程中的常规现象,可通过植入前遗传筛查在卵裂期或囊胚期检测到,导致胎盘和胎儿本身都存在嵌合体。局限嵌合体已在大脑、性腺和胎盘等部位报道。嵌合体来源于多种机制,包括染色体不分离、后期滞后或内复制。后期滞后被认为是导致植入前胚胎中嵌合体产生的主要过程。此外,嵌合体可能由来自父系、母系或外源性因素(如培养基)或体外受精(IVF)期间可能的控制性卵巢过度刺激等多种因素引起。在分别来自 IVF 的卵裂期和囊胚期胚胎中,报道的嵌合体率高达 70%和 90%。
嵌合体的临床后果取决于涉及的染色体以及发生错误的时间和位置。减数分裂错误或早期有丝分裂错误的有丝分裂挽救通常会导致普遍嵌合体,而特定细胞谱系点的有丝分裂错误通常会导致局限嵌合体。嵌合体的临床后果取决于许多方面,每个事件的后果都是独特的。